Home
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,800 public trials 303 recruiting studies

Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Not Yet Recruiting

Real World Asparaginase Therapy Toxicity

NCT07008027

Conditions: Chemically-Induced Disorders, Drug Toxicity, Drug-Related Side Effects and Adverse Reactions, +12 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Not Yet Recruiting

A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia

NCT07283640

Conditions: Blinatumomab, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: MD Anderson Cancer Houston, Texas, United States

View Trial Details

Not Yet Recruiting

SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS

NCT07575412

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Azacytidine, +17 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

NCT07634653

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoid Leukemia, +19 more
Locations: University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

View Trial Details

Not Yet Recruiting

A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL)

NCT07614022

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Atrium Health Levine Cancer Charlotte, North Carolina, United States

Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Not Yet Recruiting

CAR-T Treatment in Pediatric and Adult Acute Lymphoblastic Leukemia

NCT07623655

Conditions: Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase I Study of FXS0683 in the Treatment of Blood Tumors

NCT07616089

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B-cell Lymphoma, +18 more
Locations: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

NCT07573111

Conditions: Acute Leukemia, Bone Marrow Diseases, Hematologic Diseases, +14 more
Locations: Lucille Packard Children's Hospital of Stanford University Palo Alto, California, United States

View Trial Details

Not Yet Recruiting

Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission

NCT07577531

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

NCT07301424

Conditions: Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), BCR-ABL Positive Acute Lymphoblastic Leukemia, Hematologic Diseases, +10 more
Locations: University of Alberta Edmonton, Alberta, Canada

View Trial Details

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Related conditions